Publication | Closed Access

Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design

UrologyPrior LinesGenitourinary CancerMedicineClinical TrialsAdvanced Urothelial CarcinomaOutcomes ResearchTrial DesignCancer TreatmentOncologyRadiation OncologyTreatment Plan EvaluationHealth Sciences